Latex allergens.
Slater
Jay E
JE
U.S. Food and Drug Administration, Bethesda, Maryland, USA.
D000485:Allergens / Q000009:adverse effects* / Q000145:classification*; D003429:Cross Reactions; D003888:Desensitization, Immunologic; D006282:Health Personnel; D028482:Hevea / Q000009:adverse effects / Q000145:classification; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D007840:Latex / Q000009:adverse effects* / Q000145:classification*; D020315:Latex Hypersensitivity / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D009784:Occupational Diseases / Q000175:diagnosis / Q000628:therapy; D012307:Risk Factors
D000485:Allergens; D007840:Latex